Shared Savings Models Could Yield Part B Savings
Skylar Jeremias | The Center for Biosimilars
“The establishment of a shared savings model has the potential to increase health care savings, biologic competition, and biosimilar utilization if implemented in Medicare Part B, according to Alex Brill, founder of Matrix Global Advisors (MGA) and a resident fellow at the American Enterprise Institute (AEI), who makes the case in a new research paper.
‘If properly structured, such a program could yield significant savings to the Medicare program and establish valuable insights into the impact of pharmaceutical reimbursement on physician prescribing patterns among physician-administered drugs,’ Brill said.”